Literature DB >> 18266299

Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.

Christoph Hölscher1, Norbert Reiling, Ulrich E Schaible, Alexandra Hölscher, Clara Bathmann, Daniel Korbel, Insa Lenz, Tanja Sonntag, Svenja Kröger, Shizuo Akira, Horst Mossmann, Carsten J Kirschning, Hermann Wagner, Marina Freudenberg, Stefan Ehlers.   

Abstract

The role of Toll-like receptors (TLR) and MyD88 for immune responses to Mycobacterium tuberculosis (Mtb) infection remains controversial. To address the impact of TLR-mediated pathogen recognition and MyD88-dependent signaling events on anti-mycobacterial host responses, we analyzed the outcome of Mtb infection in TLR2/4/9 triple- and MyD88-deficient mice. After aerosol infection, both TLR2/4/9-deficient and wild-type mice expressed pro-inflammatory cytokines promoting antigen-specific T cells and the production of IFN-gamma to similar extents. Moreover, TLR2/4/9-deficient mice expressed IFN-gamma-dependent inducible nitric oxide synthase and LRG-47 in infected lungs. MyD88-deficient mice expressed pro-inflammatory cytokines and were shown to expand IFN-gamma-producing antigen-specific T cells, albeit in a delayed fashion. Only mice that were deficient for MyD88 rapidly succumbed to unrestrained mycobacterial growth, whereas TLR2/4/9-deficient mice controlled Mtb replication. IFN-gamma-dependent restriction of mycobacterial growth was severely impaired only in Mtb-infected MyD88, but not in TLR2/4/9-deficient bone marrow-derived macrophages. Our results demonstrate that after Mtb infection neither TLR2, -4, and -9, nor MyD88 are required for the induction of adaptive T cell responses. Rather, MyD88, but not TLR2, TLR4 and TLR9, is critical for triggering macrophage effector mechanisms central to anti-mycobacterial defense.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266299     DOI: 10.1002/eji.200736458

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  77 in total

Review 1.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

2.  The RD1 locus in the Mycobacterium tuberculosis genome contributes to activation of caspase-1 via induction of potassium ion efflux in infected macrophages.

Authors:  Takeshi Kurenuma; Ikuo Kawamura; Hideki Hara; Ryosuke Uchiyama; Sylvia Daim; Sita Ramyamali Dewamitta; Shunsuke Sakai; Kohsuke Tsuchiya; Takamasa Nomura; Masao Mitsuyama
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

3.  Mycobacterium tuberculosis Hip1 dampens macrophage proinflammatory responses by limiting toll-like receptor 2 activation.

Authors:  Ranjna Madan-Lala; Katia Vitorello Peixoto; Fabio Re; Jyothi Rengarajan
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 4.  C-type lectins with a sweet spot for Mycobacterium tuberculosis.

Authors:  G Lugo-Villarino; D Hudrisier; A Tanne; O Neyrolles
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

5.  A role for IL-18 in protective immunity against Mycobacterium tuberculosis.

Authors:  Bianca E Schneider; Daniel Korbel; Kristine Hagens; Markus Koch; Bärbel Raupach; Jana Enders; Stefan H E Kaufmann; Hans-Willi Mittrücker; Ulrich E Schaible
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

6.  Critical role of toll-like receptor 9 in morphine and Mycobacterium tuberculosis-Induced apoptosis in mice.

Authors:  Lin Chen; Wanliang Shi; Hui Li; Xiuli Sun; Xionglin Fan; Gene Lesage; Hui Li; Yi Li; Yi Zhang; Xiumei Zhang; Ying Zhang; Deling Yin
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

7.  The adaptor molecule CARD9 is essential for tuberculosis control.

Authors:  Anca Dorhoi; Christiane Desel; Vladimir Yeremeev; Lydia Pradl; Volker Brinkmann; Hans-Joachim Mollenkopf; Karin Hanke; Olaf Gross; Jürgen Ruland; Stefan H E Kaufmann
Journal:  J Exp Med       Date:  2010-03-29       Impact factor: 14.307

8.  Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.

Authors:  Amber Troy; Sandra C Esparza-Gonzalez; Alicia Bartek; Elizabeth Creissen; Linda Izzo; Angelo A Izzo
Journal:  Tuberculosis (Edinb)       Date:  2020-06-06       Impact factor: 3.131

9.  A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis.

Authors:  Antoine Tanne; Bo Ma; Frédéric Boudou; Ludovic Tailleux; Hélène Botella; Edgar Badell; Florence Levillain; Maureen E Taylor; Kurt Drickamer; Jérome Nigou; Karen M Dobos; Germain Puzo; Dietmar Vestweber; Martin K Wild; Marie Marcinko; Peter Sobieszczuk; Lauren Stewart; Daniel Lebus; Brigitte Gicquel; Olivier Neyrolles
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

10.  Attenuation of toll-like receptor expression and function in latent tuberculosis by coexistent filarial infection with restoration following antifilarial chemotherapy.

Authors:  Subash Babu; Sajid Q Bhat; N Pavan Kumar; R Anuradha; Paul Kumaran; P G Gopi; C Kolappan; V Kumaraswami; Thomas B Nutman
Journal:  PLoS Negl Trop Dis       Date:  2009-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.